Edition:
United States

Eyenovia Inc (EYEN.OQ)

EYEN.OQ on NASDAQ Stock Exchange Capital Market

8.30USD
25 May 2018
Change (% chg)

$0.16 (+1.97%)
Prev Close
$8.14
Open
$8.21
Day's High
$8.50
Day's Low
$8.21
Volume
4,044
Avg. Vol
--
52-wk High
$10.60
52-wk Low
$7.16

Latest Key Developments (Source: Significant Developments)

Eyenovia Reports Q4 Loss Per Share $0.84
Monday, 2 Apr 2018 06:30am EDT 

April 2 (Reuters) - Eyenovia Inc ::EYENOVIA ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS.Q4 LOSS PER SHARE $0.84.‍AS OF DECEMBER 31, 2017, COMPANY'S CASH WAS APPROXIMATELY $5.2 MILLION​.‍ EXPECTS TO ANNOUNCE FULL AND DETAILED RESULTS FOR EYN PG21 CLINICAL STUDY IN Q2 OF 2018​.  Full Article

Eyenovia Advances Micropine For Myopia Into Phase III Clinical Development
Wednesday, 21 Feb 2018 08:30am EST 

Feb 21 (Reuters) - Eyenovia Inc ::EYENOVIA ADVANCES MICROPINE FOR MYOPIA INTO PHASE III CLINICAL DEVELOPMENT AND APPOINTS STANFORD PROFESSOR DR. DOUGLAS FREDRICK TO ITS SCIENTIFIC ADVISORY BOARD AND MYOPIA PROGRAM STEERING COMMITTEE.EYENOVIA INC - MICROPINE PHASE III TRIAL FOR MYOPIA IS PLANNED TO START IN FIRST HALF OF 2019.EYENOVIA INC - EYENOVIA HAS RECEIVED FEEDBACK THAT ONLY ONE PHASE III PIVOTAL STUDY WILL BE REQUIRED FOR REGISTRATION INSTEAD OF TWO TRIALS.  Full Article

Eyenovia Announces Pricing Of Initial Public Offering
Thursday, 25 Jan 2018 06:30am EST 

Jan 25 (Reuters) - Eyenovia Inc ::EYENOVIA ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING.SAYS INITIAL PUBLIC OFFERING OF 2.73 MILLION COMMON SHARES PRICED AT $10.00PER SHARE.  Full Article

Eyenovia Announces Appointment Of John Gandolfo As CFO
Tuesday, 9 Jan 2018 08:00am EST 

Jan 9 (Reuters) - Eyenovia Inc ::EYENOVIA INC - APPOINTMENT OF JOHN GANDOLFO AS CHIEF FINANCIAL OFFICER EFFECTIVE DECEMBER 18, 2017.EYENOVIA ANNOUNCES APPOINTMENT OF JOHN GANDOLFO AS CHIEF FINANCIAL OFFICER.  Full Article

Eyenovia Sees IPO Of 2.73 Mln Shares Of Common Stock Priced Between $10-$12 Per Share
Tuesday, 9 Jan 2018 07:00am EST 

Jan 9 (Reuters) - Eyenovia Inc ::EYENOVIA INC SEES IPO OF 2.73 MILLION SHARES OF COMMON STOCK PRICED BETWEEN $10.00 AND $12.00 PER SHARE - SEC FILING.EYENOVIA SAYS INTENDS TO USE IPO PROCEEDS TOGETHER WITH EXISTING CASH, ABOUT $12 MILLION TO COMPLETE PHASE III CLINICAL TRIALS FOR MICROPROST.EYENOVIA SAYS INTENDS TO USE IPO PROCEEDS TOGETHER WITH EXISTING CASH, ABOUT $2 MILLION TO COMPLETE PHASE III CLINICAL TRIALS FOR MICROSTAT.EYENOVIA SAYS INTENDS TO USE IPO PROCEEDS TOGETHER WITH EXISTING CASH, ABOUT $1.5 MILLION TO COMPLETE MICROTEARS REGISTRATION ACTIVITIES.  Full Article

BRIEF-Eyenovia Reports Q1 Loss Per Share Of $0.45

* EYENOVIA REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND COMPLETION OF EYN PG21 STUDY